Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Prestige Consumer Healthcare (PBH) EBIT Margin: 2009-2025

Historic EBIT Margin for Prestige Consumer Healthcare (PBH) over the last 17 years, with Sep 2025 value amounting to 29.06%.

  • Prestige Consumer Healthcare's EBIT Margin fell 65.00% to 29.06% in Q3 2025 from the same period last year, while for Sep 2025 it was 29.88%, marking a year-over-year increase of 59.00%. This contributed to the annual value of 29.60% for FY2025, which is 83.00% down from last year.
  • Per Prestige Consumer Healthcare's latest filing, its EBIT Margin stood at 29.06% for Q3 2025, which was up 1.07% from 28.76% recorded in Q2 2025.
  • Prestige Consumer Healthcare's 5-year EBIT Margin high stood at 33.93% for Q2 2021, and its period low was -98.30% during Q1 2023.
  • Over the past 3 years, Prestige Consumer Healthcare's median EBIT Margin value was 29.72% (recorded in 2024), while the average stood at 18.13%.
  • In the last 5 years, Prestige Consumer Healthcare's EBIT Margin crashed by 12,730bps in 2023 and then skyrocketed by 12,795bps in 2024.
  • Quarterly analysis of 5 years shows Prestige Consumer Healthcare's EBIT Margin stood at 30.09% in 2021, then spiked by 155bps to 31.64% in 2022, then tumbled by 93bps to 30.71% in 2023, then skyrocketed by 97bps to 31.68% in 2024, then tumbled by 65bps to 29.06% in 2025.
  • Its last three reported values are 29.06% in Q3 2025, 28.76% for Q2 2025, and 29.82% during Q1 2025.